MedTrace Logo

Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA)

NCT02197273 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 211

Last updated 2016-10-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total joint arthroplasty, as compared to standard of care analgesia.

Conditions

  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Osteoarthritis, Shoulder

Interventions

DRUG

Liposomal bupivacaine

DRUG

Standard of care analgesia

Sponsors & Collaborators

  • OhioHealth

    lead OTHER

Principal Investigators

  • Deborah Napier, BSN,RN,MA · OhioHealth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-09-30
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02197273 on ClinicalTrials.gov